http://www.xconomy.com/san-diego/2008/12/15/california-stem-cell-agency-awards-grants-cohu-buys-german-rival-amylin-gets-go-ahead-more-san-diego-biztech-news/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 09:14:03 +0000 hourly 1 http://wordpress.org/?v=3.0.4 http://www.xconomy.com/san-diego/2008/12/15/california-stem-cell-agency-awards-grants-cohu-buys-german-rival-amylin-gets-go-ahead-more-san-diego-biztech-news/comment-page-1/#comment-240634 The beauty of stem cells | Pharma Strategy Blog Wed, 27 Oct 2010 01:15:51 +0000 http://www.xconomy.com/?p=6908#comment-240634 [...] California Stem Cell Agency Awards Grants, Cohu Buys German Rival, Amylin Gets Go-Ahead, & More ... (xconomy.com) This entry was posted in Cell Therapy, Current Affairs, News, Science, Technology and tagged competitive intelligence, KOL market research, M&A due diligence portfolio analysis, pharmaceutical biotechnology marketing strategy. Bookmark the permalink. ← Tumour suppressor genes and ATOH1 in colorectal cancer Hot oncology drugs that may receive approval in 2009 → blog comments powered by Disqus /* */ /* */ /* */ [...] [...] California Stem Cell Agency Awards Grants, Cohu Buys German Rival, Amylin Gets Go-Ahead, & More … (xconomy.com) This entry was posted in Cell Therapy, Current Affairs, News, Science, Technology and tagged competitive intelligence, KOL market research, M&A due diligence portfolio analysis, pharmaceutical biotechnology marketing strategy. Bookmark the permalink. ← Tumour suppressor genes and ATOH1 in colorectal cancer Hot oncology drugs that may receive approval in 2009 → blog comments powered by Disqus /* */ /* */ /* */ [...]

]]>